Jon P. Stonehouse
Chief Executive Officer, BioCryst Pharmaceuticals.
Companies
- Metsera, Inc.Board member Apr 30, 2025 to now1
- BioCryst PharmaceuticalsBoard member Jan 9, 2007 to now2
- BioCryst PharmaceuticalsChief executive officer Jan 9, 2007 to now2
- BioCryst PharmaceuticalsPresident Aug 14, 2007 to Dec 23, 20243
- BELLICUM PHARMACEUTICALS, INCBoard member Dec 17, 2014 to Jan 5, 20234
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
BioCryst Pharmaceuticals BCRX1,380,419 shares5$11.0M at $7.99Sep 2, 2026- BELLICUM PHARMACEUTICALS, INC204,086 shares6Jan 3, 2023
- Metsera, Inc.0 shares7Nov 13, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 31, 2026Granted 644 shares at $9.70 of BioCryst Pharmaceuticals5
- Jun 11, 2026Granted 15,294 shares of BioCryst Pharmaceuticals8
- May 29, 2026Granted 631 shares at $8.91 of BioCryst Pharmaceuticals9
- Mar 2, 2026Returned to company 305,995 shares at $8.64 of BioCryst Pharmaceuticals10
- Mar 2, 2026Exercised options 305,995 shares at $3.22 of BioCryst Pharmaceuticals10
- Feb 27, 2026Granted 421 shares at $8.75 of BioCryst Pharmaceuticals10
- Dec 19, 2025Shares withheld for tax 61,793 shares at $7.41 of BioCryst Pharmaceuticals11
- Dec 18, 2025Gift 10,000 shares of BioCryst Pharmaceuticals12
- Dec 18, 2025Gift 10,000 shares of BioCryst Pharmaceuticals12
- Dec 18, 2025Gift 20,000 shares of BioCryst Pharmaceuticals12
- Dec 12, 2025Shares withheld for tax 27,368 shares at $7.57 of BioCryst Pharmaceuticals13
- Nov 13, 2025Returned to company 2,688 shares of Metsera, Inc.7
- Dec 20, 2024Gift 10,000 shares of BioCryst Pharmaceuticals14
- Dec 20, 2024Gift 10,000 shares of BioCryst Pharmaceuticals14
- Dec 20, 2024Gift 20,000 shares of BioCryst Pharmaceuticals14
- Dec 19, 2024Shares withheld for tax 14,010 shares at $7.39 of BioCryst Pharmaceuticals14
- Dec 19, 2024Granted 362,100 shares of BioCryst Pharmaceuticals14
- Dec 14, 2024Shares withheld for tax 27,525 shares at $7.53 of BioCryst Pharmaceuticals15
- May 13, 2024Bought 30,000 shares at $5.55 of BioCryst Pharmaceuticals16
- Jan 3, 2024Gift 10,000 shares of BioCryst Pharmaceuticals17
- Jan 3, 2024Gift 10,000 shares of BioCryst Pharmaceuticals17
- Jan 3, 2024Gift 20,000 shares of BioCryst Pharmaceuticals17
- Dec 19, 2023Shares withheld for tax 14,089 shares at $6.05 of BioCryst Pharmaceuticals18
- Dec 14, 2023Shares withheld for tax 13,592 shares at $6.43 of BioCryst Pharmaceuticals19
- Dec 14, 2023Granted 127,500 shares of BioCryst Pharmaceuticals19
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMetsera, Inc., Board member
- 2
- 3SEC EDGARBioCryst Pharmaceuticals, President
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Jun 15, 2026
- 9SEC EDGARForm 4 filed Jun 2, 2026
- 10SEC EDGARForm 4 filed Mar 3, 2026
- 11SEC EDGARForm 4 filed Dec 23, 2025
- 12SEC EDGARForm 4 filed Dec 19, 2025
- 13SEC EDGARForm 4 filed Dec 16, 2025
- 14SEC EDGARForm 4 filed Dec 23, 2024
- 15SEC EDGARForm 4 filed Dec 17, 2024
- 16SEC EDGARForm 4 filed May 15, 2024
- 17SEC EDGARForm 4 filed Jan 4, 2024
- 18SEC EDGARForm 4 filed Dec 20, 2023
- 19SEC EDGARForm 4 filed Dec 18, 2023